Please provide your email address to receive an email when new articles are posted on . Newly announced ACR guidelines recommend against glucocorticoids as first-line therapy for interstitial lung ...
Interstitial lung disease (ILD) progression in patients with systemic sclerosis–associated ILD (SSc-ILD) did not predict subsequent progression at the next annual follow-up, with only 20% showing ...
Individuals with interstitial lung disease (ILD) had more than a 13-fold higher incidence rate of lung cancer than those without ILD. The association persisted after adjustment for confounders, was ...
Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for early clinical recognition. Supplemental oxygen therapy in fibrotic ILD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results